In the FVB-huHER2 transgenic mouse model, prophylactic HER2 vaccination significantly prevented tumor formation in mice, while in the xenograft tumor model, injection of serum from DNA-vaccinated mice significantly inhibited the growth of human HER2-positive tumors (De Giovanni et al., 2014). Here, ERBB2 is linked to neoplasm.